GRTS
Income statement / Annual
Last year (2023), Gritstone bio, Inc.'s total revenue was $1.33 M,
a decrease of 85.64% from the previous year.
In 2023, Gritstone bio, Inc.'s net income was -$138.49 M.
See Gritstone bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
Operating Revenue |
$1.33 M
|
$9.27 M
|
$46.72 M
|
$4.04 M
|
$4.37 M
|
$1.19 M
|
$0.00
|
$0.00
|
Cost of Revenue |
$7.59 M |
$15.69 M |
$14.40 M |
$88.64 M |
$82.90 M |
$54.97 M |
$1.97 M |
$823,000.00 |
Gross Profit |
-$6.26 M |
-$6.42 M |
$32.32 M |
-$84.61 M |
-$78.53 M |
-$53.78 M |
-$1.97 M |
-$823,000.00 |
Gross Profit Ratio |
-4.7 |
-0.69 |
0.69 |
-20.96 |
-17.99 |
-45.31 |
0 |
0 |
Research and Development
Expenses |
$127.18 M
|
$111.40 M
|
$97.49 M
|
$88.64 M
|
$82.90 M
|
$54.97 M
|
$35.69 M
|
$13.92 M
|
General & Administrative
Expenses |
$28.78 M
|
$28.97 M
|
$25.93 M
|
$21.41 M
|
$19.41 M
|
$11.81 M
|
$6.07 M
|
$5.06 M
|
Selling & Marketing
Expenses |
-$7.59 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$21.19 M
|
$28.97 M
|
$25.93 M
|
$21.41 M
|
$19.41 M
|
$11.81 M
|
$6.07 M
|
$5.06 M
|
Other Expenses |
-$32,000.00 |
-$10.68 M |
-$1.50 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$148.37 M |
$129.70 M |
$121.93 M |
$110.05 M |
$102.31 M |
$66.77 M |
$41.76 M |
$18.98 M |
Cost And Expenses |
$155.97 M |
$129.70 M |
$121.93 M |
$110.05 M |
$102.31 M |
$66.77 M |
$41.76 M |
$18.98 M |
Interest Income |
$5.20 M |
$1.98 M |
$127,000.00 |
$703,000.00 |
$3.51 M |
$809,000.00 |
$386,000.00 |
$230,000.00 |
Interest Expense |
$4.04 M |
$1.24 M |
$37,000.00 |
$12,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$7.59 M
|
$15.69 M
|
$14.40 M
|
$6.64 M
|
$4.75 M
|
$3.96 M
|
$1.97 M
|
$823,000.00
|
EBITDA |
-$147.04 M
|
-$118.45 M
|
-$68.86 M
|
-$99.37 M
|
-$93.20 M
|
-$61.62 M
|
-$39.79 M
|
-$18.16 M
|
EBITDA Ratio |
-110.48 |
-12.78 |
-1.47 |
-24.62 |
-21.35 |
-51.91 |
0 |
0 |
Operating Income Ratio
|
-116.18
|
-12.99
|
-1.61
|
-26.26
|
-22.44
|
-55.25
|
0
|
0
|
Total Other
Income/Expenses Net |
$16.14 M
|
$741,000.00
|
$127,000.00
|
$703,000.00
|
$3.51 M
|
$809,000.00
|
$386,000.00
|
$230,000.00
|
Income Before Tax |
-$138.49 M |
-$119.69 M |
-$75.08 M |
-$105.31 M |
-$94.43 M |
-$64.78 M |
-$41.38 M |
-$18.75 M |
Income Before Tax Ratio
|
-104.05
|
-12.91
|
-1.61
|
-26.09
|
-21.63
|
-54.57
|
0
|
0
|
Income Tax Expense |
$7.42 M |
-$6.56 M |
-$127,000.00 |
-$703,000.00 |
-$3.51 M |
$809,000.00 |
$0.00 |
$0.00 |
Net Income |
-$138.49 M |
-$113.13 M |
-$74.96 M |
-$104.61 M |
-$90.93 M |
-$64.78 M |
-$41.38 M |
-$18.75 M |
Net Income Ratio |
-104.05 |
-12.2 |
-1.6 |
-25.91 |
-20.83 |
-54.57 |
0 |
0 |
EPS |
-1.2 |
-1.24 |
-0.95 |
-2.77 |
-2.71 |
-7.26 |
-2.06 |
-0.93 |
EPS Diluted |
-1.2 |
-1.24 |
-0.95 |
-2.77 |
-2.71 |
-7.26 |
-2.06 |
-0.93 |
Weighted Average Shares
Out |
$115.53 M
|
$90.92 M
|
$78.89 M
|
$37.79 M
|
$33.55 M
|
$8.92 M
|
$20.09 M
|
$20.09 M
|
Weighted Average Shares
Out Diluted |
$115.53 M
|
$90.92 M
|
$78.89 M
|
$37.79 M
|
$33.55 M
|
$8.92 M
|
$20.09 M
|
$20.09 M
|
Link |
|
|
|
|
|
|
|
|